Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Interventions listed in this trial
			immune globulin
5		Additional drug interventions recognized in this trial
			Immunoglobulins
			Immunoglobulins, Intravenous
6		More general drug interventions related to this trial
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
7		Sponsors listed in this trial
			National Institute of Neurological Disorders and Stroke (NINDS)
			Mayo Clinic